MedDRA coding agent awarded for redefining pharmacovigilance through advanced automation, accuracy, and customer impact.
Leading life sciences AI technology company ArisGlobal, creator of LifeSphere®, announced that it has received the 2025 Frost & Sullivan Award in the “Innovative New Global Product” category for its Intelligent MedDRA Coding. This recognition recognizes ArisGlobal’s groundbreaking MedDRA Coding Agent, the industry’s first agentic AI built for pharmacovigilance, which is transforming how safety data is coded, analyzed, and delivered.
ArisGlobal launched its MedDRA Coding Agent in April 2025 , quickly garnering market interest. The solution applies agentic AI to mimic human judgment in medical coding, eliminating the limitations of static, rule-based systems. Unlike traditional automation tools, the MedDRA Coding Agent dynamically interprets clinical language, chooses appropriate reasoning paths, and consolidates its knowledge from reviewer feedback to continuously improve its accuracy and transparency.
Key Features of MedDRA Coding Agent:
- Agent understanding of context : interpretation of clinical language beyond keywords, understanding of meaning and intent.
- Continuous learning loop: real-time adaptation to reviewer corrections and changes in MedDRA terminology.
- Explainable and verifiable decisions : transparent reasoning, ensuring compliance with regulations.
- Multilingual agent designed for the enterprise : supporting global operations, integrations, and validation requirements.
- Adaptive collaboration : proposing hierarchical and rational coding options, consulting the higher echelon only when necessary.
This next-generation approach has delivered significant efficiencies in coding operations, reducing the burden of manual review while increasing consistency and compliance across large, global teams.
Independent Validation by Frost & Sullivan
In its analysis, Frost & Sullivan praised ArisGlobal for “reinventing pharmacovigilance with context-aware agentic systems that deliver measurable operational and compliance benefits.”
Norazah Bachok, Best Practices Research Analyst at Frost & Sullivan, comments: “The MedDRA coding agent is scalable, auditable, and enterprise-ready, driving efficiency gains of up to 80% by significantly reducing reviewer workload and eliminating redundancy, without compromising accuracy. It’s clear that ArisGlobal is placing innovation at the center of its growth strategy, with LifeSphere NavaX being the cornerstone of its AI vision.”
“The MedDRA Coding Agent represents a major advancement in pharmacovigilance automation,” said Jason Bryant, Senior Vice President of AI Product Management at ArisGlobal. “By combining the cognitive depth of Agentic AI with the proven capabilities of LifeSphere NavaX, we are transforming complex coding workflows into resourceful, adaptive processes that improve accuracy and efficiency at scale. This innovation underscores our continued investment in R&D and our unwavering commitment to automation across the safety and regulatory value chain. And we have no plans to slow down: this is just the first of many agents we will launch to help the industry reimagine what’s possible.”
Also Read: Will Rompala Named CTO at Life Science Connect
The Frost & Sullivan Best Practices Awards recognize companies worldwide for outstanding achievements in leadership, technological innovation, customer service, and strategic product development. The Innovative New Product Award is the highest honor, bestowed upon businesses in recognition of visionary innovation, market-leading performance, and unparalleled customer service.
ArisGlobal distinguished itself in Frost & Sullivan’s rigorous evaluation of strategy effectiveness and execution by demonstrating its strong alignment with evolving market needs and operational excellence. This recognition underscores ArisGlobal‘s impact on innovation, customer value, and industry performance standards.
Source: PRNewswire